Cited by 1,763Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationHeart Failure Treatment and Management

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Open access

Køber, Lars, Thune, Jens J., Nielsen, Jens C., Haarbo, Jens, Videbæk, Lars, Korup, Eva, Jensen, Gunnar, Hildebrandt, Per, Steffensen, Flemming H., Bruun, Niels E., Eiskjær, Hans, Brandes, Axel, Thøgersen, Anna M., Gustafsson, Finn, Egstrup, Kenneth, Videbæk, Regitze, Hassager, Christian, Svendsen, Jesper H., Høfsten, Dan E., Torp-Pedersen, Christian, Pehrson, Steen·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1608029

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT). METHODS: In a randomized, controlled trial, 556 patients with symptomatic systolic heart failure (left ventricular ejection fraction, ≤35%) not caused by coronary artery disease were assigned to receive an ICD, and 560 patients were assigned to receive usual clinical care (control group). In both groups, 58% of the patients received CRT. The primary outcome of the trial was death from any cause. The secondary outcomes were sudden cardiac death and cardiovascular death. RESULTS: After a median follow-up period of 67.6 months, the primary outcome had occurred in 120 patients (21.6%) in the ICD group and in 131 patients (23.4%) in the control group (hazard ratio, 0.87; 95% confidence interval [CI], 0.68 to 1.12; P=0.28). Sudden cardiac death occurred in 24 patients (4.3%) in the ICD group and in 46 patients (8.2%) in the control group (hazard ratio, 0.50; 95% CI, 0.31 to 0.82; P=0.005). Device infection occurred in 27 patients (4.9%) in the ICD group and in 20 patients (3.6%) in the control group (P=0.29). CONCLUSIONS: In this trial, prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease was not associated with a significantly lower long-term rate of death from any cause than was usual clinical care. (Funded by Medtronic and others; DANISH ClinicalTrials.gov number, NCT00542945 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1608029

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Moss, A. J., Schuger, C. D., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., Estes, N. A. M., Greenberg, H., Hall, W. J., Huang, D. T.-C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211107 · Cited by 1,369

Show all 18 references

Sorted by citations

Items 601–700 of 999

Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis
Menezes, A. D. S., Lopes, C. C., Cavalcante, P. F., & Martins, E. (2018) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2017-0134 · Cited by 11
Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy
Voskoboinik, A., Wong, M. C. G., Elliott, J. K., Costello, B. T., Prabhu, S., Mariani, J. A., Kalman, J. M., Kistler, P. M., Taylor, A. J., & Morton, J. B. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13426 · Cited by 11
Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?
Kovacs, B., Reek, S., Krasniqi, N., Eriksson, U., & Duru, F. (2018) · Cardiology Research and Practice · doi:10.1155/2018/7373610 · Cited by 11
Why Dyssynchrony Matters in Heart Failure?
Tayal, B., Søgaard, P., & Risum, N. (2018) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2018.11.006 · Cited by 11
The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure
Rørth, R., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L. M., Korup, E., Signorovitch, J., Bruun, N. E., Eiskjær, H., Hassager, C., et al. (2019) · EP Europace · doi:10.1093/europace/euz114 · Cited by 11
Self-citation
Registro Español de Desfibrilador Automático Implantable. XV Informe Oficial de la Sección de Electrofisiología y Arritmias de la Sociedad Española de Cardiología (2018)
Lozano, I. F., Osca, J., & Rodríguez, J. A. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.07.029 · Cited by 11
The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape
Wong, J. A., Roberts, J. D., & Healey, J. S. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.024 · Cited by 11
Sex and Heart Failure Treatment Prescription and Adherence
Farrero, M., Bellumkonda, L., Otero, I. G., & Molina, B. D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.630141 · Cited by 12
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE
Shen, L., Claggett, B. L., Jhund, P. S., Abraham, W. T., Desai, A. S., Dickstein, K., Gong, J., Køber, L., Lefkowitz, M., Rouleau, J. L., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01888-x · Cited by 11
Self-citation
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature
Valenti, A. C., Albini, A., Imberti, J. F., Vitolo, M., Bonini, N., Lattanzi, G., Schnabel, R. B., & Boriani, G. (2022) · Biology · doi:10.3390/biology11040530 · Cited by 11
Long-term outcome of cardiac resynchronization therapy patients in the elderly
Behon, A., Merkel, E. D., Schwertner, W. R., Kuthi, L. K., Veres, B., Masszi, R., Kovács, A. D., Lakatos, B. K., Zima, E., Gellér, L., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00739-z · Cited by 16
Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis
Hutt, E., Vega, M., Goldar, G., Aguilera, J., Wang, T. K. M., Taimeh, Z. A., Culver, D. A., Callahan, T. D., Tang, W. H. W., Cremer, P. C., et al. (2023) · EP Europace · doi:10.1093/europace/euad273 · Cited by 11
Two-Year Outcomes of Primary Prophylactic Use of Defibrillators for Ischemic and Non-Ischemic Cardiomyopathy ― Propensity Score-Matched Analysis From the Nippon Storm Study ―
Kondo, Y., Noda, T., Takanashi, Y., Sasaki, S., Sato, Y., Nitta, T., Aizwa, Y., Ohe, T., & Kurita, T. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0613 · Cited by 11
Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy—State of Art and Perspectives
Argentiero, A., Carella, M. C., Mandunzio, D., Greco, G., Mushtaq, S., Baggiano, A., Fazzari, F., Fusini, L., Muscogiuri, G., Basile, P., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247752 · Cited by 11
Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials
Romero, J. E., Chaudhary, R., Garg, J., Lupercio, F. A., Shah, N., Gupta, R., Nazir, T. F., Bozorgnia, B., Natale, A., & Biase, L. D. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-017-0260-8 · Cited by 11
Primary Prevention Implantable Cardiac Defibrillator Trials
Sroubek, J., & Buxton, A. E. (2017) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.08.006 · Cited by 11
Extending Survival by Reducing Sudden Death with Implantable Cardioverter-Defibrillators: A Challenging Clinical Issue in Non-Ischaemic and Ischaemic Cardiomyopathies
Boriani, G., & Malavasi, V. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1080 · Cited by 11
Incorporating patients’ preference diagnosis in implantable cardioverter defibrillator decision-making
Lewis, K. B., Carroll, S. L., Birnie, D. H., Stacey, D., & Matlock, D. D. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000464 · Cited by 11
Contemporary approach to treating heart failure
Brann, A. M., Tran, H. A., & Greenberg, B. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.11.011 · Cited by 12
Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction
Fernández-Vázquez, D., Ferrero‐Gregori, A., Garcia, J. A., Otero, I. G., Vázquez, R., Delgado, J. F., Diz, F. W., Bardajı́, A., García‐Pavía, P., Bayés‐Genís, A., et al. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.09.030 · Cited by 11
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis
Stolfo, D., Albani, S., Savarese, G., Barbati, G., Ramani, F., Gigli, M., Biondi, F., Ferro, M. D., Zecchin, M., Merlo, M., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.02.025 · Cited by 11
Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
Hadwiger, M., Frielitz, F., Eisemann, N., Elsner, C., Dagres, N., Hindricks, G., & Katalinic, A. (2020) · Applied Health Economics and Health Policy · doi:10.1007/s40258-020-00571-y · Cited by 10
A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy
Falco, M. D., Genovesi, D., Caravatta, L., CARLO, C. D., Bliakharskaia, E., Appignani, M., Faustino, M., Furia, N., & Girolamo, E. D. (2020) · Strahlentherapie und Onkologie · doi:10.1007/s00066-020-01651-7 · Cited by 11
Coste-efectividad del desfibrilador automático implantable para la prevención primaria de la muerte súbita cardiaca
Ribera, A., Giménez, E., Oristrell, G., Osorio, D., Marsal, J. R., García‐Pérez, L., Ballesteros, M., Ródenas‐Alesina, E., Belahnech, Y., Escalona, R., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.02.015 · Cited by 11
Prognostic Value of Feature-Tracking Circumferential Strain in Dilated Cardiomyopathy Patients with Severely Reduced Ejection Fraction Incremental to Late Gadolinium Enhancement
Shu, S., Wang, J., Wang, C., Zhu, F., Jia, Y., Zhang, L., Zhou, X., Zhang, T., & Zheng, C. (2021) · Current Medical Science · doi:10.1007/s11596-021-2331-4 · Cited by 11
CRT Pacing: Midterm Follow-Up in LV Only Pacing without RV Lead in Patients with Normal AV Conduction
Cozma, D. C., Văcărescu, C., Petrescu, L., Mornoş, C., Goanta, E. V., Feier, H. B., Luca, C. T., Guşetu, G., & Vatasescu, R. G. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120531 · Cited by 11
Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry
Frommeyer, G., Andresen, D., İnce, H., Maier, S. K. G., Stellbrink, C., Kleemann, T., Seidl, K., Hoffmann, E., Zrenner, B., Hochadel, M., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-018-01337-2 · Cited by 11
Selecting Patients With Nonischemic Dilated Cardiomyopathy for ICDs
Cleland, J. G. F., Halliday, B. P., & Prasad, S. K. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.748 · Cited by 11
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy
Al‐Khatib, S. M., & Pokorney, S. D. (2017) · Circulation · doi:10.1161/circulationaha.117.030935 · Cited by 11
Infections of cardiac implantable electronic devices: still a cause of high mortality
Goette, A., & Sommer, P. (2021) · EP Europace · doi:10.1093/europace/euab139 · Cited by 11
Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know
Ursaru, A. M., Petriş, A. O., Costache, I. I., Nicolae, A., Crişan, A. S., & Tesloianu, D. N. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9040120 · Cited by 10
Management of Ventricular Arrhythmias in Heart Failure
Vázquez‐Calvo, S., Roca‐Luque, I., & Althoff, T. F. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00608-y · Cited by 11
Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines
Badger, S., McVeigh, J., & Indraratna, P. (2023) · Cardiology and Therapy · doi:10.1007/s40119-023-00328-3 · Cited by 13
Effect of Implantable Cardioverter-defibrillators in Nonischemic Heart Failure According to Background Medical Therapy: Extended Follow-up of the DANISH Trial
Yafasova, A., Doi, S. N., Thune, J. J., Nielsen, J. C., Haarbo, J., Bruun, N. E., Gustafsson, F., Eiskjær, H., Hassager, C., Svendsen, J. H., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.04.017 · Cited by 10
Self-citation
Prognostic relevance of global work index and global constructive work in patients with non-ischemic dilated cardiomyopathy
Chen, P., Aurich, M., Greiner, S., Maliandi, G., Müller‐Hennessen, M., Giannitsis, E., Meder, B., Frey, N., Pleger, S. T., & Mereles, D. (2024) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-024-03144-5 · Cited by 10
Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy
Kubánek, M., Bínová, J., Piherová, L., Krebsová, A., Kotrč, M., Hartmannová, H., Hodaňová, K., Mušálková, D., Stránecký, V., Paleček, T., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15009 · Cited by 10
Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes
Zhou, D., Zhu, L., Li, S., Wu, W., Zhuang, B., Xu, J., Yang, W., He, J., Wang, Y., Zhang, Y., et al. (2025) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.124.017246 · Cited by 11
Spanish Implantable Cardioverter-defibrillator Registry. 16th Official Report of the Heart Rhythm Association of the Spanish Society of Cardiology (2019)
Lozano, I. F., Osca, J., & Rodríguez, J. A. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.07.015 · Cited by 10
Meta‐analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy
Basu‐Ray, I., Khanra, D., Shah, S. K., Mukherjee, A., Char, S. V., Jain, B., Bunch, T. J., Gold, M. R., Adeboye, A. A., & Saeed, M. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14129 · Cited by 10
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.
Thoi, F., Scherer, D., Kaye, D., Sanders, P., & Stokes, M. (2022) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2021.12.015 · Cited by 10
Registro español de desfibrilador automático implantable. XVIII informe oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2021)
Lozano, I. F., Asensi, J. O., & Rodríguez, J. A. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2022.07.014 · Cited by 10
Contemporary updates on ventricular arrhythmias: from mechanisms to management
Bhaskaran, A., Silva, K. D., & Kumar, S. (2022) · Internal Medicine Journal · doi:10.1111/imj.15976 · Cited by 10
Clinical implications of cardiac magnetic resonance imaging fibrosis
Guglielmo, M., & Pontone, G. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac085 · Cited by 10
Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
Rizzello, V. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac087 · Cited by 10
State of the Art of Cardiac Amyloidosis
Belfeki, N., Ghriss, N., Monchi, M., & Moini, C. (2023) · Biomedicines · doi:10.3390/biomedicines11041045 · Cited by 10
Outcomes of patients admitted with ventricular arrhythmias and sudden cardiac death in the United States
Viles-González, J. F., Arora, S., Deshmukh, A. J., Atti, V., Agnihotri, K., Patel, N., Dave, M., Anter, E., Garcia, F. C., Santangeli, P., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.09.007 · Cited by 10
Contemporary benefit‐harm profile over two decades in primary prophylactic ICD‐therapy
Kleemann, T., Strauss, M., Kouraki, K., Lampropoulou, E., Fendt, A., Werner, N., & Zahn, R. (2019) · Clinical Cardiology · doi:10.1002/clc.23234 · Cited by 12
Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
Foo, F. S., Lee, M., Looi, K., Larsen, P., Clare, G. C., Heaven, D., Stiles, M. K., Voss, J., Boddington, D., Jackson, R., et al. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12244 · Cited by 10
The role of entirely subcutaneous ICD™ systems in patients with dilated cardiomyopathy
Willy, K., Reinke, F., Bögeholz, N., Ellermann, C., Rath, B., Köbe, J., Eckardt, L., & Frommeyer, G. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.10.005 · Cited by 10
Multimodality imaging predictors of sudden cardiac death
Bandera, F., Baghdasaryan, L., Mandoli, G. E., & Cameli, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09893-z · Cited by 10
Mildly Symptomatic Heart Failure with Reduced Ejection Fraction: Diagnostic and Therapeutic Considerations
Arvanitaki, A., Michou, E., Kalogeropoulos, A. P., Karvounis, H. I., & Giannakoulas, G. A. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12701 · Cited by 9
Biventricular Pacemaker and Defibrillator Implantation in Patients with Chronic Heart Failure in China
Huang, D., Hua, W., Fang, Q., Yan, J., Su, Y., Liu, B., Xu, Y., Peng, Y., & POSCD-China Investigators (2020) · ESC Heart Failure · doi:10.1002/ehf2.13114 · Cited by 9
Heart failure treatment in patients with cardiac implantable electronic devices: Opportunity for improvement
Salimian, S., Deyell, M. W., Andrade, J. G., Chakrabarti, S., Bennett, M. T., Krahn, A. D., & Hawkins, N. M. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.09.010 · Cited by 10
NT-proBNP and ICD in Nonischemic Systolic Heart Failure
Butt, J. H., Yafasova, A., Elming, M. B., Dixen, U., Nielsen, J. C., Haarbo, J., Videbæk, L. M., Korup, E., Bruun, N. E., Eiskjær, H., et al. (2022) · JACC Heart Failure · doi:10.1016/j.jchf.2022.01.003 · Cited by 10
Self-citation
N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator
Deng, Y., Cheng, S., Hua, W., Cai, M., Zhang, N., Niu, H., Chen, X., Gu, M., Cai, C., Liu, X., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.823076 · Cited by 10
Nonischemic Super-Responders in Fusion CRT Pacing with Normal Atrioventricular Conduction
Goanță, E.-V., Luca, C. T., Văcărescu, C., Crișan, S., Petrescu, L., Vatasescu, R. G., Lazăr, M.-A., Gurgu, A., Turi, V., & Cozma, D. C. (2022) · Diagnostics · doi:10.3390/diagnostics12092032 · Cited by 10
Kommentar zu den Leitlinien 2022 der ESC zu ventrikulären Arrhythmien und Prävention des plötzlichen Herztodes
Eckardt, L., Könemann, H., Bosch, R., Deneke, T., Falk, V., Perings, C. A., Schulz‐Menger, J., & Meyer, C. G. (2023) · Die Kardiologie · doi:10.1007/s12181-022-00589-7 · Cited by 10
Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy
Cavalcanti, R., Aboul‐Hosn, N., MORALES, G. X., & Abdel‐Latif, A. (2017) · Angiology · doi:10.1177/0003319717710851 · Cited by 10
Predicting defibrillator benefit in patients with cardiac resynchronization therapy: A competing risk study
Weber, D., Koller, M., Theuns, D. A. M. J., Yap, S., Kühne, M., Sticherling, C., Reichlin, T., Szili‐Törok, T., Osswald, S., & Schaer, B. A. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.01.033 · Cited by 10
The Implantable Cardioverter Defibrillator
Gold, M. R. (2005) · Wiley eBooks · doi:10.1002/9780470750674.ch8 · Cited by 9
ICD Implantation in Patients with Nonischemic Heart Failure
Køber, L., Nielsen, J. C., & Pehrson, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1614441 · Cited by 10
Self-citation
Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipientsPreprint
Olausson, E., Wertz, J., Fridman, Y., Bering, P. T., Maanja, M., Niklasson, L., Wong, T. C., Fukui, M., Cavalcante, J. L., Cater, G. M., et al. (2023) · medRxiv · doi:10.1101/2023.02.15.23285925 · Cited by 10
2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Imaging in patients with cardiovascular implantable electronic devices: part 1—imaging before and during device implantation. A clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association (EHRA) of the ESC
Stanković, I., Voigt, J., Burri, H., Muraru, D., Sade, L. E., Haugaa, K. H., Lumens, J., Biffi, M., Dacher, J., Marsan, N. A., et al. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead272 · Cited by 9
Incremental prognostic value of left atrial and biventricular feature tracking in dilated cardiomyopathy: a long-term study
Xiang, X., Song, Y., Zhao, K., Yu, S., Yang, S., Xu, J., Wang, J., Dong, Z., Ma, X., Wei, Z., et al. (2023) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-023-00967-4 · Cited by 9
Registro español de desfibrilador automático implantable. XX informe oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2023)
Asensi, J. O., Lozano, I. F., Rodríguez, J. A., & Calvo, D. (2024) · Revista Española de Cardiología · doi:10.1016/j.recesp.2024.08.001 · Cited by 9
Cardiac implantable electronic device infection
Christie, S., McGregor, M., & Krahn, A. D. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.02.001 · Cited by 9
Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis
Canepa, M., Anastasia, G., Ameri, P., Vergallo, R., O’Connor, C. M., Sinagra, G., & Porto, I. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.02.004 · Cited by 9
Cardiac Rhythm Devices in Heart Failure with Reduced Ejection Fraction – Role, Timing, and Optimal Use in Contemporary Practice. European Journal of Heart Failure Expert Consensus Document
Bozkurt, B., Müllens, W., Leclercq, C., Russo, A. M., Savarese, G., Böhm, M., Hill, L., Kinugawa, K., Sato, N., Abraham, W. T., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3641 · Cited by 10
Artificial intelligence in ventricular arrhythmias and sudden cardiac death: A guide for clinicians
Antoun, I., Li, X., Abdelrazik, A., Eldesouky, M., Thu, K. M., Ibrahim, M. N., Dhutia, H., Somani, R., & Ng, G. A. (2025) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2025.09.005 · Cited by 11
Engineering Artificial Spider Silk From Biomimetic Synthesis to Advanced Applications
Zhou, B., Zhou, Q., Liu, Z., Zhou, X. Y., & Bao, L. (2025) · SmartSys · doi:10.1002/sys3.70005 · Cited by 9
Long-Term Effect of ICDs in Nonischemic Heart Failure With Reduced Ejection Fraction
Butt, J. H., Doi, S. N., Thune, J. J., Nielsen, J. C., Videbæk, L. M., Yafasova, A., Bruun, N. E., Torp-Pedersen, C. T., Eiskjær, H., Egstrup, K., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.089 · Cited by 9
Self-citation
Global Registries and Surveys Programme–Heart Failure (GRASP-HF): Rationale, Study Design and Research Implications
Chioncel, O., Savarese, G., Laroche, C., Amir, O., Tokmakova, M. P., Cannata, A. N., Do, D. L., Kafafy, T. A., Krejčí, J., Moura, B., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70065 · Cited by 9
Clinical Implications of Fragmented QRS Complex as an Outcome Predictor in Children with Idiopathic Dilated Cardiomyopathy
Kong, Y., Song, J., Kang, I., & Huh, J. (2020) · Pediatric Cardiology · doi:10.1007/s00246-020-02473-1 · Cited by 9
Contemporary ICD Use in Patients with Heart Failure
Spartalis, Μ., Nakajima, K., Zweiker, D., Spartalis, E. D., Iliopoulos, D., & Siasos, G. (2021) · Cardiology and Therapy · doi:10.1007/s40119-021-00225-7 · Cited by 9
Prognostic Differences in Long-Standing vs. Recent-Onset Dilated Cardiomyopathy
Silverdal, J., Sjöland, H., Pivodic, A., Dahlström, U., Fu, M. L. X., & Bollano, E. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13816 · Cited by 7
Effectiveness of Implantable Cardioverter Defibrillator in Patients With Non-Ischemic Heart Failure With Systolic Dysfunction ― Subanalysis of the Nippon Storm Study ―
Sasaki, S., Noda, T., Okumura, K., Nitta, T., Aizawa, Y., Ohe, T., & Kurita, T. (2022) · Circulation Journal · doi:10.1253/circj.cj-22-0187 · Cited by 9
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause
Khan, M. S., Butler, J., Anker, S. D., Filippatos, G. S., Ferreira, J. P., Pocock, S., Januzzi, J. L., Piña, I. L., Böhm, M., Ponikowski, P. P., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027652 · Cited by 9
Big Endothelin-1 as a Predictor of Reverse Remodeling and Prognosis in Dilated Cardiomyopathy
Feng, J., Liang, L., Chen, Y., Tian, P., Zhao, X., Huang, B., Wu, Y., Wang, J., Guan, J., Huang, L., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041363 · Cited by 9
ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death
Casolo, G., Gulizia, M. M., Aschieri, D., Chinaglia, A., Corda, M., Nassiacos, D., Caico, S. I., Chimenti, C., Giaccardi, M., Gotti, E., et al. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad101 · Cited by 9
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for heart failure?
Kronborg, M. B., Frausing, M. H. J. P., Svendsen, J. H., Johansen, J. B., Riahi, S., Haarbo, J., Poulsen, S. H., Eiskjær, H., Køber, L., Øvrehus, K. A., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.05.011 · Cited by 9
Self-citation
Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study
Dichtl, W., de Sousa, J., López, J. M. R., Campo, E. G., Gutleben, K., Poezevara, Y., & Probst, V. (2023) · EP Europace · doi:10.1093/europace/euad186 · Cited by 9
Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients
Disertori, M., Masè, M., Rigoni, M., Nollo, G., Arbustini, E., & Ravelli, F. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00873 · Cited by 9
Arrhythmogenic Inflammatory Cardiomyopathy: A Review
Bauer, B. S., Li, A. C., & Bradfield, J. S. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.26.2 · Cited by 10
Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure
Christie, S., Hiebert, B. M., Seifer, C. M., & Khoo, C. (2018) · Journal of Arrhythmia · doi:10.1002/joa3.12131 · Cited by 8
Current challenges in sudden cardiac death prevention
Corrado, D., Zorzi, A., Vanoli, E., & Gronda, E. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09830-0 · Cited by 9
Self-reported health status and the associated risk of mortality in heart failure: The DANISH trial
Bundgaard, J. S., Thune, J. J., Torp-Pedersen, C. T., Nielsen, J. C., Haarbo, J., Rørth, R., Videbæk, L. M., Melchior, T. M., Pedersen, S. S., Køber, L., et al. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110220 · Cited by 8
Self-citation
Real-World Outcomes in Cardiac Resynchronization Therapy Patients: Design and Baseline Demographics of the SMART- Registry
Gardner, R. S., D’Onofrio, A., Mark, G. E., Gras, D., Hu, Y. L., Veraghtert, S., & García‐Bolao, I. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13192 · Cited by 8
Nomogram Predicting Death and Heart Transplantation Before Appropriate ICD Shock in Dilated Cardiomyopathy
Deng, Y., Zhang, N., Hua, W., Cheng, S., Niu, H., Chen, X., Gu, M., Cai, C., Liu, X., Huang, H., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13808 · Cited by 9
Echocardiographic predictors of ventricular arrhythmias in patients with non-ischemic cardiomyopathy
Harapoz, M., Zada, M., Matthews, J. G., Kumar, S., & Thomas, L. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.100962 · Cited by 9
Spanish Implantable Cardioverter-defibrillator Registry. 13th Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2016)
Alzueta, J., & Lozano, I. F. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.07.011 · Cited by 9
Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death among Patients With Cancer
Zadok, O. I. B., Agmon, I. N., Neiman, V., Eisen, A., Golovchiner, G., Bental, T., Schamroth-Pravda, N., Kadmon, E., Goldenberg, G. R., Erez, A., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.12.013 · Cited by 9
Noninvasive electrocardiographic risk factors for sudden cardiac death in dilated ca rdiomyopathy: is ambulatory electrocardiography still relevant?
Milaras, N., Dourvas, P., Doundoulakis, I., Sotiriou, Z., Nevras, V., Xintarakou, A., Laina, A., Σουλαϊδόπουλος, Σ., Zachos, P., Kordalis, A., et al. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10300-x · Cited by 9
Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients
Lewenhardt, M., Kreimer, F., Aweimer, A., Pflaumbaum, A., Mügge, A., & Gotzmann, M. (2023) · Clinical Cardiology · doi:10.1002/clc.24191 · Cited by 9
Effectiveness of Implantation of Cardioverter-Defibrillators Therapy in Patients with Non-Ischemic Heart Failure: an Updated Systematic Review and Meta-Analysis
Xing, Z., Tang, L. V., Chen, C., Huang, J., Zhu, Z., & Hu, X. (2017) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2017-0003 · Cited by 9
Prevention of sudden cardiac death by the implantable cardioverter-defibrillator
Hindricks, G., Lenarczyk, R., Kalarus, Z. F., Döring, M., Shamloo, A. S., & Dagres, N. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4386 · Cited by 9
GDMT for heart failure and the clinician's conundrum
Samarendra, P. (2019) · Clinical Cardiology · doi:10.1002/clc.23268 · Cited by 9
Patient Outcome after Implant of a Cardioverter Defibrillator in the ‘Real World’: The Key Role of Co-Morbidities
Boriani, G., & Malavasi, V. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.743 · Cited by 9
Reconsidering arrhythmic risk stratification in dilated cardiomyopathy – Beyond ventricular contractility and gene mutability
Gatzoulis, K. A., KANOUPAKIS, E. M., Antoniou, C. K., Sideris, A., & Kolettis, T. M. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.07.008 · Cited by 9
Review: Sex-related differences in the treatment of cardiac arrhythmia
Haum, M., Kellnar, A., Thienel, M., & Lackermair, K. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108388 · Cited by 8

Authors: Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., Eiskjær, H., Brandes, A., Thøgersen, A. M., Gustafsson, F., Egstrup, K., Videbæk, R., Hassager, C., Svendsen, J. H., Høfsten, D. E., Torp-Pedersen, C., & Pehrson, S.
Affiliations: University of Copenhagen (DK)
ORCID: Køber, Lars
Thune, Jens J.
Nielsen, Jens C.
Videbæk, Lars
Steffensen, Flemming H.
Bruun, Niels E.
Eiskjær, Hans
Brandes, Axel
Thøgersen, Anna M.
Gustafsson, Finn
Egstrup, Kenneth
Hassager, Christian
Svendsen, Jesper H.
Høfsten, Dan E.
Torp-Pedersen, Christian
Pehrson, Steen
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2016-09-29
Volume: 375
Issue: 13
Pages: 1221-1230
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1608029
OpenAlex: W2518530324
Cited by: 1,763
References: 18
Citations by year: 2026: 104 · 2025: 138 · 2024: 139 · 2023: 170 · 2022: 182 · 2021: 177 · 2020: 196 · 2019: 212 · 2018: 200 · 2017: 213 · 2016: 28
FWCI: 179.55
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, other-oa)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Scopus (Elsevier) (submittedVersion)
VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
Funders: Bristol-Myers Squibb
Pfizer
AstraZeneca
Sanofi
Gilead Sciences
Hjerteforeningen
Boston Scientific Corporation
TrygFonden
Servier
St. Jude Medical
Biosense Webster
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: implantable cardioverter-defibrillator, prophylactic ICD, heart failure with reduced ejection fraction, non-ischemic heart failure, sudden cardiac death, all-cause mortality, cardiac resynchronization therapy, device-related infection, left ventricular ejection fraction, DANISH trial
MeSH terms: Aged, Cardiac Pacing, Artificial, Cardiovascular Diseases, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mortality, Stroke Volume, Death, Sudden, Cardiac, Defibrillators, Implantable, Heart Failure, Systolic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks